Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.00
Bid: 1,670.50
Ask: 1,671.00
Change: 17.00 (1.03%)
Spread: 0.50 (0.03%)
Open: 1,650.00
High: 1,677.00
Low: 1,646.00
Prev. Close: 1,653.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. Stocks on the Move-Energy stocks, Lands' End, Synthesis

Wed, 10th Dec 2014 18:03

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)

U.S. stocks were lower near midday on Wednesday, weighed down bya sharp decline in the energy sector on the latest weakness inoil prices. The Dow Jones industrial average was down0.86 percent at 17,647.51, the S&P 500 was down 0.76percent at 2,044.21 and the Nasdaq Composite was down0.65 percent at 4,735.57.

** GLAXOSMITHKLINE PLC, $43.22, -2.02 pct

Bank of America Merrill Lynch cut its rating to"underperform" from "neutral" on Britain's biggest drugmaker, citing near-term margin pressures, lower long-termexpectations for new respiratory products and reduced buybacksgiven lower earnings.

** SEVENTY SEVEN ENERGY INC, $4.81, -14.87 pct

** REX ENERGY CORP, $5.17, -5.40 pct

** SANCHEZ ENERGY CORP, $7, -7.53 pct

** HALCON RESOURCES CORP, $1.735, -8.68 pct

** WHITING PETROLEUM CORP, $31.25, -6.86 pct

** BREITBURN ENERGY PARTNERS LP, $9.36, -8.50 pct

** CALIFORNIA RESOURCES CORP, $5.68, -7.19 pct

Oil and gas companies' stocks fell as global oil pricestouched a five-year low and at least 4 brokerages cut ratingsand price targets on about 50 companies. Brent crude oil fell more than $2 a barrel to a new five-year low on forecaststhat oversupply would keep building until next year after OPECdecided not to cut output.

** CONOCOPHILLIPS, $63.37, -2.45 pct

** CHEVRON CORP, $103.708, -3.09 pct

** ENERGY XXI (BERMUDA) LTD, $2.95, -7.81 pct

** GOODRICH PETROLEUM CORP, $3.53, -13.69 pct

** OASIS PETROLEUM INC, $11.6, -8.37 pct

** CONTINENTAL RESOURCES INC, $33.82, -6.52 pct

** HESS CORP, $68.85, -4.61 pct

U.S. oil and gas producers are scaling back capital spendingplans for 2015, following a sharp decline in oil prices over thepast six months. Global oil and gas exploration projects worthmore than $150 billion are likely to be put on hold in 2015 asplunging oil prices render them uneconomic, according to datafrom Norwegian consultancy Rystad Energy.

** YUM! BRANDS INC, $71.58, -4.84 pct

At least three brokerages, including Barclays Capital, cutprice targets on the stock after the company on Tuesday loweredits full-year profit forecast for the second time, hurt by aslower-than-expected recovery in China after a food safety scarein July.

"The question remains whether the China segment will everreturn to full strength," Barclays analyst Jeffrey Bernsteinwrote in a note, cutting his price target to $74 from $75.

** AMERICAN AIRLINES GROUP INC, $49.8784, +3.25 pct

** UNITED CONTINENTAL HOLDINGS INC, $65.5, +4.77 pct

** DELTA AIR LINES INC, $46.95, +1.34 pct

** SOUTHWEST AIRLINES CO, $42.5, +4.35 pct

** JETBLUE AIRWAYS, $15.46, +2.76 pct

** UNITED CONTINENTAL, $65.5, +4.77 pct

U.S. airline operators' shares rose after Barclays saidlower oil prices may help companies next year. Airlines stand tosee a decline of about $10 billion in fuel costs in 2015,analyst David Fintzen wrote in a note.

** LANDS' END INC, $46.75, -7.72 pct

The apparel retailer's third-quarter revenue fell 3 percentdue to lower international sales and weaker sales at its shopswithin Sears Holdings Corp outlets. Lands' End was spunoff from Sears last year.

** SYNTHESIS ENERGY SYSTEMS INC, $0.9975, +16.00pct

The clean energy company's China joint venture partner,Zhangjiagang Chemical Machinery Co Ltd, securedorders worth more than $105 million for three industrial syngassupply plants.

** ALLOT COMMUNICATIONS LTD, $8.2, -9.29 pct

BofA Merrill Lynch downgraded the Israel-based bandwidthmanagement services company's U.S.-listed shares to"underperform" from "buy" and cut its target price to $10.5 from$17.

"We have concerns over Allot's key fundamentals, weakcarrier spending, uncertainty surrounding Title 2 reform (thatenables FCC to enforce net neutrality) in the US and recentmanagement departures," BofA analysts wrote in a note.

** COMSTOCK RESOURCES INC, $5.76, -11.52 pct

FBR & Co cut its price target to $8.50 from $20 on the oiland gas producer's shares, citing low commodity prices andexpectations of continued volatility.

** FRANCESCA'S HOLDINGS CORP, $15.485, +2.35 pct

The women's apparel and accessories retailer's third-quarternet sales rose 9 percent to $87.1 million, driven by a 53percent rise in e-commerce sales. Suntrust Robinson Humphreyanalyst Pamela Quintiliano said the company's fourth-quarterprofit forecast of 13-19 cents per share reflects a realisticbar for new Chief Executiver Michael Barnes.

** LAYNE CHRISTENSEN CO, $8.13, +13.07 pct

The water management company's third-quarter net loss fromcontinuing operations narrowed to 19 cents per share from 79,while analysts on average expected a loss of 50 cents per share.The company also appointed Michael Caliel from Invensys Ltd as Chief Executive after Rene Robichaud quit in June.

** VAALCO ENERGY INC, $4.66, -18.25 pct

The oil and gas company shut its Etame 8-H well offshoreGabon due to the production of hydrogen sulfide during initialtests. The company said investigations are underway to determinethe cause of sulfide production.

** CHC GROUP LTD, $3.88, -11.42 pct

The commercial helicopter operator reported second-quarterrevenue below the average analyst estimate as some customers inthe oil and gas industry delayed or canceled projects.

** YAMANA GOLD INC, $4.385, +1.98 pct

The Canadian gold miner said it will place some ofits Brazilian assets that have been deemed non-core into asubsidiary dubbed Brio Gold and will explore a potential salealong with other options for the unit in 2015.

The company said the assets being parceled off into BrioGold include Fazenda Brasileiro, C1 Santa Luz and Pilar, and itsAgua Rica project.

** PETROQUEST ENERGY INC, $3.74, -6.27 pct

FBR Capital Markets cut its price target to $6 from $8 onthe oil and gas producer's stock, citing weak oil and gasprices, slower production growth and lower capex levels.

** HOVNANIAN ENTERPRISES INC, $4.23, +8.46 pct

The U.S. homebuilder's fourth-quarter revenue jumped 18percent and orders rose 8 percent as the U.S. housing marketrecovery picks up.

** TUNIU CORP, $11.96, +5.84 pct

** CTRIP.COM, $43.461, -1.11 pct

The companies announced an agreement to expand collaborationon shared travel resources. Ctrip bought $15 million of TuniuClass A shares in May; it currently owns over 3 percent ofTuniu's outstanding shares.

** BEMIS CO INC, $42.87, +4.15 pct

BMO Capital Markets raised its rating on Tuesday to"outperform" from "market perform" and price target to $47 from$39 on the packaging material maker's stock.

An expected fall in the price of resin, which accounts for alarge part of costs, to boost company's margin, analysts wrotein note.

** SILICON GRAPHICS INTERNATIONAL CORP, $10.09,+5.43 pct

Needham & Company LLC upgraded the supercomputing servermaker's stock to "buy" from "hold".

"We are encouraged that Congress seems to be activelyworking together regarding the upcoming Federal Budget deadlineof Dec. 11, and this should provide relief to companies like SGI(Silicon Graphics) that are closely tied to Federal spendingcycles" - Needham analysts.

** CIVEO CORP, $7.64, -15.02 pct

The workforce accommodation provider's stock is to bereplaced by KLX Inc in the S&P MidCap 400 index aftermarket close on Dec. 16. Civeo gave a weak forecast lateSeptember and dropped plans of converting to a REIT.

** SEVCON INC, $8.7792, +12.41 pct

The controls maker for electric and hybrid vehicles won acontract to supply motor controllers to a "Tier-1 automotivesupplier" in Southeast Asia. The company said the contract couldresult in $50 million in revenue through 2020.

** CYREN LTD, $2.28, +30.73 pct

The Israeli cloud-based cyber security provider said some of its technology will be used in China-based mobileapplication security provider Bangcle's products. Bangcle'ssecurity software covers 500 million mobile phones worldwide.

** WARREN RESOURCES INC, $1.42, -11.80 pct

The oil and gas producer said it was deferring crude oildevelopment in Wilmington oil field due to weak prices. Warrensaid it expects capital spending to drop to about $80 million in2015.

** ENERGOUS CORP, $7.45, -6.88 pct

The company, which is developing technology to chargeelectronic devices wirelessly, priced a public offering of 2.9million shares at $7 per share, a discount of 12.5 percent tothe stock's Tuesday closing.

** BELDEN INC, $80.43, +7.35 pct

The networking and cable product maker said on Tuesday thatit would buy Portland-based cyber security firm Tripwire for$710 million. The deal is expected to add 65 cents per share toBelden's adjusted income from continuing operations in 2015.

** ARCA BIOPHARMA INC, $0.9688, +20.95 pct

ARCA said the U.S. Food and Drug Administration granted itsexperimental drug orphan drug status as a potential treatmentfor viral hemorrhagic fever after exposure to the Ebola virus.

** JPMORGAN CHASE & CO, $61.32, -1.81 pct

Fed Vice Chairman Stanley Fischer says the bank will needmore than $20 billion of additional capital to comply with theproposed extra capital cushion for the largest U.S. banks.

"While we're still reviewing the Fed's proposal, we are wellcapitalized and intend to meet their requirements and timeframes...," JPMorgan spokesman Andrew Gray said.

** CYTORI THERAPEUTICS INC, $0.5225, +12.39 pct

The U.S. FDA granted conditional approval for a key clinicaltrial to evaluate the company's cell therapy as a potentialtreatment for impaired hand function in scleroderma patients.Cytori's technology, called the Celution System, needs asuccessful pivotal trial and FDA approval before it can bemarketed in the United States.

** LINN ENERGY LLC, $13.3101, -8.96 pct

Stifel analysts cut their price target on the oil and gascompany's stock to $22 from $27, citing a lower commodity priceenvironment. The median price target on stock is $25, accordingto Thomson Reuters data.

** SEADRILL LTD, $11.53, -5.26 pct

UBS cut its price target on the Norway-based offshoredriller's Oslo-listed shares to NOK 85 from NOK 210,citing lower oil prices. Analysts expect Brent to average below$70/bbl in 2015 and also cited current market condition having anegative affect on demand for deepwater units.

** KRISPY KREME DOUGHNUTS INC, $18.48, -8.42 pct

The doughnut retailer on Tuesday reported third-quarterprofit and sales below expectations, hurt by higher promotionsto boost traffic and lower sales at company-owned stores,compared with a year earlier.

** GOLDMAN SACHS, $193.84, -1.55 pct

The U.S. Federal Reserve on Tuesday proposed requiring eightof the largest U.S. banks to hold an extra capital cushion, andsaid the firms will need more equity if they rely on risky typesof debt. Most of the banks, which include Citigroup and GoldmanSachs, would be held to higher capital requirements than under asimilar rule by global regulators, officials said.

** COMTECH TELECOMMUNICATIONS CORP, $36.7, -5.78pct

The communications equipment maker decided to remainindependent after completing review of strategic alternatives.Comtech had begun its review in August, saying that merger orsale of the company was possible.

** CITIGROUP INC, $55.3, -0.98 pct

Citigroup will record $2.7 billion in litigation expensesand another $800 million in repositioning charges, leaving thethird-largest U.S. bank "marginally profitable" in the fourthquarter, its chief executive officer said on Tuesday.

** FREEPORT-MCMORAN COPPER & GOLD INC, $24.89, -0.96pct

The U.S. miner has agreed to pay 16.3 percent more in annualprocessing charges to large Chinese copper smelters in 2015,with the 10-year high fee likely to set the benchmark for China. (Compiled by Lehar Maan in Bengaluru,; Editing by SimonJennings)

More News
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.